FEELLiFE Nicotine Salt:
· Better Taste
· Better Feel
· Closer to Real
An alternative to smoking
Easy to get rid of nicotine addiction
Since the beginning, we aim at low output e-cigarettes. Our reason is to provide higher nicotine-delivery levels with smooth and satisfying flavour. It’s easy on the throat in comparison to ordinary high nicotine e-liquids. This is a revolutionary product and the nest vaping trendsetter!
Nicotine salt is a form of nicotine found in tobacco leaves. It contains nicotine and an organic acid which lowers the pH and makes it much easier to vape. The salt does not impact on the nicotine content in your e-liquid, which means you can comfortably vape high-nicotine e-liquids without additional harshness on the throat.
What’s best with the nicotine salt is that it suitable to any of new vapers who want to quit smoking. The sensation of nicotine salt brings the same as the real cigarette. Furthermore, nicotine salt allows you to have higher nicotine to achieve your cravings.
Why use Nicosalt?
● Satisfyingly smoother taste
● Achieves maximum nicotine delivery with minimal throat hit
● Longer shelf life: e-liquid not easy to volatilize and discolour
● Quicker nicotine absorption and e-juice saving
● Customised flavours and nicotine content available (20mg maximum in TPD regulated countries).
Since set up in 2009, FEELLiFE has focused on the research and development and production of e-liquid, rapidly developed into the top global e-liquid OEM manufacturer, providing high-quality e-liquid products for many well-known e-liquid brands all over the world.
With modern international standard factory, pharmaceutical grade dust-free workshop and assembly line, FEELLiFE make sure every bottle of e-liquid to meet the requirements of high quality.
Factory Address: 202 North California Ave, City of Industry CA 91744 U.S.A.
The UAE to Finally Allow The Sale of Vaping Products
Up until now, the UAE had maintained a forbidding stance towards e-cigarettes, and despite all the research indicating that the devices are effective smoking cessation tools, local authorities had insisted on upholding the illegal status of the products.
Last March, a UAE senior health official had even said that the country was working on devising regulations which would stop the illegal import of e-cigarettes, and that anyone caught smuggling the devices would be facing criminal charges.
However in a sudden U turn, last September the Emirates Authority for Standardisation and Metrology (Esma), said that it was reviewing the scientific data on alternative tobacco products, as part of a plan to establish whether the ban should be lifted.
New E-Cig Regulations: UAE.S 5030
Consequently, last Sunday ESMA confirmed that new regulations known as UAE.S 5030 will allow the legal sale of e-cigarettes and vaping devices as long as manufacturers meet new standards and carry health warnings similar to to those on traditional cigarette packets.
Abdulla Al Maeeni, director general of Esma, said concern about the spread of unregulated e-cigarettes was among the reasons behind the move, adding that many users have a “lack of knowledge of the ingredients used”. He said that by regulating sales, ESMA can ensure quality and safety standards.
Post time: Feb-22-2019
Does Vaping Increase the Risk of Stroke and Heart Attacks? A Cardiologist Responds
A recently published study and conference abstract released earlier this month concluded that “Daily e-cigarette use, adjusted for smoking conventional cigarettes as well as other risk factors, is associated with increased risk of myocardial infarction.” Similarly the media coverage of the conference abstract stated that “E-cigarettes linked to higher risk of stroke, heart attack, diseased arteries.”
Renowned cardiologist and well published tobacco harm reduction researcher Dr. Konstantinos Farsalinos, responded to these allegations saying that both conclusions are wrong and “constitute epidemiological malpractice and misinformation.”
Farsalinos explained that being cross-sectional surveys, meaning that they asked participants if they have heart disease and if they use e-cigarettes, the studies provide no information as to whether the participants initiated e-cigarette use before or after the development of the disease, or for how long. This means that the participants could have easily started vaping following a heart disease diagnosis, in order to quit smoking and improve their health.
A correlation does not equate to a causation
The researcher explained that explaining the correlation between these two factors the way that these studies did, would be similar to the association between ever using medications to lower cholesterol and having a heart attack. Farsalinos pointed out that when looking for such a correlation, of course it was found that ever use of anti-cholesterol medications was associated with a 115% higher odds (more than double the odds) of having had a heart attack.
“Should we claim that “Ever taking prescribed medicine to lower cholesterol, adjusted for having hypercholesterolemia as well as other risk factors, is associated with increased risk of heart attack”? Of course not, that would be absurd,” he said.
Farsalinos also pointed out a number of errors in the reporting of the data. “In the published study, 94.7% of daily e-cigarette users were current or former smokers. In the conference abstract, 79% of e-cigarette users were smokers (they do not mention if this refers to current only or current and former smokers).” He explained that clearly there is a problem in the analysis.
The researchers are certainly aware of the flaws in this study
The cardiologist concluded that these studies do not really provide any information about any risk associated with the use of e-cigarettes, despite claiming that they do. “They do not prove an increased risk and of course they do not prove that no such risk exists. They simply cannot address the question of whether e-cigarettes increase the risk for heart disease or not,” he said.
He added that he is confident that both the authors of the published study and the American Heart Association, which released the press statement for the conference abstract, are well aware of these basic epidemiological principles, as any scientist would.
“This is simple, basic knowledge for a medical student, let alone for acknowledged scientists. And they know that the statements about “increased risk” are wrong. So, why do they use these statements? Perhaps we should ask them…” concluded Farsalinos.
Post time: Feb-21-2019